1176 - 1200 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Isolation of Human Microglia from Neuropathologically Diagnosed Cases in the Single-Cell EraJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 43End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2655-9_3Citation Count: 2
- LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleus2022OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 20
-
RESTRICTEDTitle: Somatic CNV Detection by Single-Cell Whole-Genome Sequencing in Postmortem Human BrainJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 205End Page: 230Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2655-9_11Citation Count: 3
- Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy2022RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 8
- BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease2022OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1053591/pdfCitation Count: 0
- Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome2022OPENTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 65
- Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline2022OPENTitle: Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105221End Page: 105221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.11.013Best OA location URL: http://www.prd-journal.com/article/S1353802022003819/pdfCitation Count: 3
-
RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 9
-
RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 1
- Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial2022RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 49
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 8
-
RESTRICTEDTitle: Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1249End Page: 1267Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00973-7Citation Count: 5
- Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms2022OPENTitle: Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanismsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34667-xBest OA location URL: https://www.nature.com/articles/s41467-022-34667-x.pdfCitation Count: 126
- Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease2022OPENTitle: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14018End Page: 14018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214018Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14018/pdf?version=1668398534Citation Count: 9
-
RESTRICTEDTitle: Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic ReviewJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 368End Page: 377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29278Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29278Citation Count: 7
-
OPENTitle: Movement Disorders andSARS‐CoV‐2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448146Citation Count: 3
- APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s disease2022OPENTitle: APOE E4 is associated with impaired self-declared cognition but not disease risk or age of onset in Nigerians with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00411-xBest OA location URL: https://www.nature.com/articles/s41531-022-00411-x.pdfCitation Count: 6
- Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease2022OPENTitle: Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13985End Page: 13985Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213985Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13985/pdf?version=1668767894Citation Count: 8
- Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease2022OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 8
- Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s Disease2022OPENTitle: Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 22Start Page: 8756End Page: 8756Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22228756Best OA location URL: https://www.mdpi.com/1424-8220/22/22/8756/pdf?version=1668248220Citation Count: 5
-
OPENTitle: Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01116-2Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01116-2Citation Count: 25
- Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders2022OPENTitle: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01468-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01468-8Citation Count: 36
- Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose2022OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12835Citation Count: 9
- Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical Practice2022OPENTitle: Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13616Best OA location URL: https://doi.org/10.1002/mdc3.13616Citation Count: 4
-
RESTRICTEDTitle: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 5Start Page: 1859End Page: 1872Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac413Best OA location URL: https://academic.oup.com/brain/article-pdf/146/5/1859/50127735/awac413.pdfCitation Count: 11